Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
James A. McCubrey, Timothy L. Fitzgerald, Li V. Yang, et al.
Oncotarget (2016) Vol. 8, Iss. 8, pp. 14221-14250
Open Access | Times Cited: 100

Showing 51-75 of 100 citing articles:

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 43-62
Closed Access | Times Cited: 21
MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway
Ryoko Ichikawa, Rie Kawasaki, Aya Iwata, et al.
Oncology Reports (2020)
Open Access | Times Cited: 20
GSK-3 in liver diseases: Friend or foe?
Maria Rita Emma, Giuseppa Augello, Antonella Cusimano, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 9, pp. 118743-118743
Open Access | Times Cited: 19
Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2‐knockout mice
Shan Huang, Jiqun Wang, Hongbo Men, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 14, pp. 6828-6840
Open Access | Times Cited: 16
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties
Robin Park, Andrew L. Coveler, Ludimila Cavalcante, et al.
Biology (2021) Vol. 10, Iss. 7, pp. 610-610
Open Access | Times Cited: 16
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
Sameer A. Dhayat, Max Michael Traeger, Jan Rehkaemper, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 328-328
Open Access | Times Cited: 19
Nitric Oxide in Hematological Cancers: Partner or Rival?
Silvia Vivarelli, Luca Falzone, Maria Sofia Basile, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 5, pp. 383-401
Closed Access | Times Cited: 17
Reduction of mechanical loading in tendons induces heterotopic ossification and activation of the β-catenin signaling pathway
Tao Wang, Peilin Chen, Lianzhi Chen, et al.
Journal of Orthopaedic Translation (2021) Vol. 29, pp. 42-50
Open Access | Times Cited: 15
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
Stephen L. Abrams, Peter P. Ruvolo, Vivian Ruvolo, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 76525-76557
Open Access | Times Cited: 17
Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells
Leon M. Larcher, Tao Wang, Rakesh N. Veedu
Molecules (2019) Vol. 24, Iss. 13, pp. 2489-2489
Open Access | Times Cited: 17
GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells
Przemysław Duda, Shaw M. Akula, Stephen L. Abrams, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 10, pp. 118770-118770
Closed Access | Times Cited: 16
Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases
Guilherme Martins Silva, Rosivaldo S. Borges, Kelton L. B. Santos, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8252-8252
Open Access | Times Cited: 14
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype
Elham Kashani, Erik Vassella
Cancers (2022) Vol. 14, Iss. 21, pp. 5227-5227
Open Access | Times Cited: 9
Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer
Su‐Chi Ku, Hsin-Liang Liu, Che‐Yu Su, et al.
Aging (2022), pp. 8498-8567
Open Access | Times Cited: 9
Melatonin increases growth properties in human dermal papilla spheroids by activating AKT/GSK3β/β-Catenin signaling pathway
Sowon Bae, Yoo Gyeong Yoon, Ji Yea Kim, et al.
PeerJ (2022) Vol. 10, pp. e13461-e13461
Open Access | Times Cited: 8
Telocinobufagin and Marinobufagin Produce Different Effects in LLC-PK1 Cells: A Case of Functional Selectivity of Bufadienolides
Luciana S. Amaral, Jainne Martins Ferreira, Danilo Predes, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2769-2769
Open Access | Times Cited: 14
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
Cornelia M. Wilson, Ayaz M. Belkozhayev, Minnatallah Al-Yozbaki, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 8, pp. 1450-1478
Open Access | Times Cited: 11
Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
Maria Mortoglou, Aleksandra Buha Djordjević, Vladimir Djordjević, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 2, pp. 467-485
Open Access | Times Cited: 11
Pharmacological Effects of a Ginseng-Containing Chinese Medicine Formula in Treating Hepatocellular Carcinoma Based on Comprehensive Bioinformatics and Experimental Validation
Tianqi Gao, Rui-Sheng Zhou, Dan Huang, et al.
The American Journal of Chinese Medicine (2024), pp. 1-19
Closed Access | Times Cited: 1
Modulation of the Wound Healing through Noncoding RNA Interplay and GSK-3β/NF-κB Signaling Interaction
Xianyi Wang, Wanqiu Li, Shengdi Lu, et al.
International Journal of Genomics (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 10
GSK-3 signaling in health
James A. McCubrey, Lucio Cocco
Advances in Biological Regulation (2017) Vol. 65, pp. 1-4
Closed Access | Times Cited: 10
Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective
Sethu Parvathy Pillai Babu, V. Sivaramakrishnan, Sharathkumar R. Munisankar, et al.
Bulletin du Cancer (2022) Vol. 109, Iss. 9, pp. 960-971
Closed Access | Times Cited: 6
The prospective potential of fluoroquinolones as anticancer agents
Rania AbuBaih, Michael Atef Fawzy, Maiiada Nazmy
Journal of Modern Research (2023) Vol. 5, Iss. 1, pp. 4-10
Open Access | Times Cited: 3
Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis
Adyasha Bijay Mishra, Sudhansu Sekhar Nishank
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 3
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
Linda S. Steelman, Steve L. Abrams, Peter P. Ruvolo, et al.
Oncotarget (2017) Vol. 8, Iss. 68, pp. 113013-113033
Open Access | Times Cited: 8

Scroll to top